Literature DB >> 26556484

Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view.

N van Geel1, V Desmedt2, S De Schepper2, B Boone2, H Lapeere2, R Speeckaert2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26556484     DOI： 10.1111/bjd.14283

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

Review 2.  Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo.

Authors:  Ming-Chen Sun; Xiao-Ling Xu; Xue-Fang Lou; Yong-Zhong Du
Journal:  Int J Nanomedicine       Date:  2020-05-08

3.  The long road to valid outcomes in vitiligo.

Authors:  A Wolkerstorfer
Journal:  Br J Dermatol       Date:  2019-03       Impact factor: 9.302

4.  Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS).

Authors:  N van Geel; L Depaepe; V Vandaele; L Mertens; J Van Causenbroeck; S De Schepper; L Van Coile; A Van Reempts; A-S De Vos; J Papeleu; I Hoorens; D Mertens; A Wolkerstorfer; J E Lommerts; R Speeckaert
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-04-29       Impact factor: 9.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.